Mena FN

Ascites Fluid Removal Devices Market Dynamics Report 20262036: Risks, Supply Chain Analysis & Growth Trajectory

(MENAFN- EIN Presswire) EINPresswire/ -- The global ascites fluid removal devices market is projected to grow from USD 744.6 million in 2026 to approximately USD 1.59 billion by 2036. This steady ...
Mena FN

Ascites Fluid Removal Devices Market Valuation, ROI Potential & Long-Term Growth Prospects 20262036

(MENAFN- EIN Presswire) EINPresswire/ -- Future Market Insights (FMI), a leading market intelligence and research firm, today announced the publication of its latest industry report, "Ascites Fluid ...
Nasdaq

New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload

Early findings suggest Aquadex as a potential solution to safely and effectively remove fluid volume for liver disease patients who don’t respond to diuretics MINNEAPOLIS, Feb. 06, 2024 (GLOBE ...
Medical News Today

All about paracentesis, or abdominal tap

Paracentesis is a medical procedure that doctors perform to drain fluid from a person’s abdominal cavity. It is sometimes called an abdominal tap. Doctors refer to this buildup of fluid as ascites, ...
Business Wire

PharmaCyte Biotech Reports Positive Interim Results in Malignant Ascites Mouse Model Study

LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes, and malignant ascites using its signature ...
Nasdaq

BioVie Announces First Patient Enrolled in BIV201 Phase 2b Clinical Trial for Ascites

SANTA MONICA, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for the treatment of liver ...